Primavera Venture Partners
春华创投
Primavera Venture Partners is the English name for 春华资本 (Chunhua Capital), a global investment management firm with approximately $17 billion in assets under management . The firm operates from Beijing's Guomao CBD, where it ranks among the most prominent VC/PE funds alongside names like ZhenFund, GSR Ventures, and Hillhouse . Its investment activity spans buyout transactions—such as the acquisition of Mead Johnson's infant formula business—and early-stage venture through its affiliated 春华创投 (Chunhua Venture), which co-led the Pre-A round in 3D generative AI company VAST in 2024 . Primavera also runs a NYSE-listed SPAC vehicle, PCAC, which merged with Lanvin Group in a deal valued at roughly $1.9 billion post-combination .
AI-generated — may contain errors, please verify.
Coverage
VAST Closes New Funding Round: Is 3D the Last Ticket for AIGC?
Will 3D Be the Future?
暗涌Waves·Buyouts in China: A "Boy Who Cried Wolf" Fable
After so many cycles of euphoria and heartbreak, will Chinese buyouts finally deliver a different ending this time?
暗涌Waves·Spring Comes Quietly to Guomao
For China's investment industry at this moment, the eerily quiet Guomao feels like a metaphor.
暗涌Waves·Lanvin Group Raises Over $500 Million, Becomes First IPO for春华's SPAC Vehicle
Raised $544 million in funding.
暗涌Waves·
